Retrophin is a fully-integrated biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options. Our approach centers on our pipeline featuring clinical-stage assets targeting rare diseases with no approved treatment options, including sparsentan for focal segmental glomerulosclerosis, or FSGS, and RE-024 for pantothenate kinase-associated neurodegeneration, also known as PKAN. Research exploring the potential of early-stage assets, including RE-034, in several rare diseases is also underway. Our R&D efforts are supported by revenues from our marketed products, Chenodal®, Cholbam® and Thiola®. Retrophin is headquartered in San Diego, CA with offices in Cambridge, MA.
View Top Employees from Retrophin| Website | http://retrophin.com |
| Ticker | RTRX |
| Revenue | $164 million |
| Funding | $86 million |
| Employees | 51 (32 on RocketReach) |
| Founded | 2011 |
| Address | 3721 Valley Centre Dr, Ste 200, San Diego, California 92130, US |
| Phone | (760) 260-8600 |
| Industry | Biotechnology, Drug Manufacturing & Research, Drug Discovery, Pharmaceuticals, Science and Engineering, Biopharmaceutical, Healthcare, Health Care, Medical |
| Competitors | Atara Biotherapeutics, Keryx Biopharmaceuticals, Lexicon Pharmaceuticals, Inc., Spectrum Pharmaceuticals, Inc., Synergy Pharmaceuticals Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 325412 Companies, NAICS Code 3254 Companies |
Looking for a particular Retrophin employee's phone or email?
Retrophin Questions
The Retrophin annual revenue was $164 million in 2023.
32 people are employed at Retrophin.
Retrophin is based in San Diego, California.
The NAICS codes for Retrophin are [32, 32541, 325, 325412, 3254].
The SIC codes for Retrophin are [283, 28].
Top Retrophin Employees
-
25
-
-
31
-
23
Related Companies
